FDA Inspection 1101385 — Loma Linda University Medical Center

Loma Linda University Medical Center — FEI 2017366

The FDA completed an inspection of Loma Linda University Medical Center on August 14, 2019 in Loma Linda, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Loma Linda, CA (United States)